Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cerbella is a natural brain health supplement developed by Neurodyn Life Sciences. It is a combination of three primary bioactive components: ginsenosides (standardized from *Panax ginseng*), decaffeinated green tea catechins, and Omega-3 fatty acids (docosahexaenoic acid and eicosapentaenoic acid). The product utilizes a proprietary complexing process to enhance the bioavailability and absorption of these compounds. Clinically studied in healthy older adults, Cerbella has been shown to modify brain fMRI signals and improve cognitive domains such as attention, short-term memory, and executive function. It is marketed as a non-prescription dietary supplement for supporting mental processing speed and overall brain health in aging populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cerbella.